You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP-2)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Solid Tumors, Advanced Solid Tumors Trial (MK-0472, Pembrolizumab)

Not yet recruiting
  • Metastatic Solid Tumors
  • Advanced Solid Tumors
  • (no location specified)
May 2, 2023

Head and Neck Squamous Cell Carcinoma Trial in Tucson, San Francisco (Ruxolitinib)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Tucson, Arizona
  • +1 more
Sep 22, 2022

Advanced Solid Tumor, Advanced or Metastatic NSCLC Trial in Guanzhou, Chengdu (BBP-398)

Recruiting
  • Advanced Solid Tumor
  • Advanced or Metastatic Non-small Cell Lung Cancer
  • Guanzhou, Guangdong, China
  • +1 more
Nov 30, 2022

Multiple Myeloma, Refractory Trial in Washington, Hackensack, Neptune (Pembrolizumab, Belantamab mafodotin, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma, Refractory
  • Washington, District of Columbia
  • +2 more
Aug 5, 2022

Danon Disease Trial in La Jolla, Philadelphia (RP-A501)

Recruiting
  • Danon Disease
  • RP-A501
  • La Jolla, California
  • +1 more
Oct 17, 2023

Covid19 Trial in New York (C144-LS and C-135-LS)

Completed
  • Covid19
  • C144-LS and C-135-LS
  • New York, New York
    The Rockefeller University
Aug 2, 2022

Non-Alcoholic Fatty Liver Disease Trial in Japan, United States (LY3849891, Placebo)

Recruiting
  • Non-Alcoholic Fatty Liver Disease
  • Rialto, California
  • +9 more
Dec 8, 2022

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Denmark, Norway, Sweden (KAND567, Carboplatin)

Recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • Odense, Denmark
  • +3 more
Oct 16, 2023

NSCLC, Colorectal Cancer, Pancreatic Ductal Carcinoma Trial in United States (JAB-3312)

Recruiting
  • Non-small Cell Lung Cancer
  • +6 more
  • Denver, Colorado
  • +3 more
Mar 13, 2022

Multiple Sclerosis COVID-19/Vaccination Treated With Ofatumumab

Completed
  • Multiple Sclerosis
    • East Hanover, New Jersey
      Novartis
    Jul 14, 2023

    Dental Caries in A Group of Egyptian Different Growth Rates: A

    Not yet recruiting
    • Dental Caries in Children
    • No intervention
    • (no location specified)
    Nov 1, 2022

    Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC) Trial in United States (pepinemab + pembrolizumab)

    Recruiting
    • Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)
    • pepinemab + pembrolizumab
    • Springdale, Arkansas
    • +17 more
    Dec 7, 2022

    Type2 Diabetes, Cognitive Impairment, Mild Trial in Kaohsiung (cognitive stimulation, as usual care)

    Completed
    • Type2 Diabetes Mellitus
    • Cognitive Impairment, Mild
    • cognitive stimulation
    • as usual care
    • Kaohsiung, Taiwan
      Yong-Kang Clinic
    Jun 8, 2023

    Tumors Trial in Spain, United States (TSR-022, Nivolumab, TSR-042)

    Recruiting
    • Neoplasms
    • Goodyear, Arizona
    • +71 more
    Dec 9, 2022

    Fibronectin Type ? Domain Containing Protein 5 \ Irsin Gene

    Recruiting
    • Hepatitis B, Chronic
    • genotyping
    • Sohag, Egypt
      Sohag university Hospital
    Sep 4, 2023

    Advanced Upper Gastrointestinal Tract Adenocarcinoma Trial in United States (Zimberelimab, Domvanalimab, Nivolumab)

    Recruiting
    • Advanced Upper Gastrointestinal Tract Adenocarcinoma
    • Hot Springs, Arkansas
    • +11 more
    Dec 6, 2022

    Advanced Breast Cancer Trial in Changsha (TQB3909 tablets)

    Recruiting
    • Advanced Breast Cancer
    • TQB3909 tablets
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Mar 16, 2023

    Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute

    Recruiting
    • Astrocytoma, Grades II, III and IV
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 31, 2023

    NSCLC, Colorectal Cancer, Pancreatic Ductal Carcinoma Trial in Beijing, Henan (JAB-3312)

    Recruiting
    • Non-small Cell Lung Cancer
    • +6 more
    • Beijing, Beijing, China
    • +4 more
    Dec 28, 2021

    Glaucoma, Open-Angle Trial (Citicoline eye drops 2%, Placebo)

    Not yet recruiting
    • Glaucoma, Open-Angle
    • Citicoline eye drops 2%
    • Placebo
    • (no location specified)
    Feb 7, 2023

    Idiopathic Pulmonary Fibrosis Trial in Birmingham (Venetoclax)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • Birmingham, Alabama
      A. Brent Carter
    Aug 3, 2023

    Alcohol Use Disorder Trial (Prazosin + cyproheptadine, KT110)

    Not yet recruiting
    • Alcohol Use Disorder
    • Prazosin + cyproheptadine
    • KT110
    • (no location specified)
    Nov 27, 2023

    Psoriasis Vulgaris Trial in San Francisco (deucravacitinib)

    Not yet recruiting
    • Psoriasis Vulgaris
    • San Francisco, California
      University of California, San Francisco
    May 4, 2023

    Solid Tumor Trial in Shanghai (HB002.1T)

    Completed
    • Solid Tumor
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Jul 26, 2021

    Double Vaccinated for COVID-19 (For Phase 1 of the Study), Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory

    Recruiting
    • Double Vaccinated for COVID-19 (For Phase 1 of the Study)
    • Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)
    • COVAC-2
    • Saline Placebo
    • Burlington, Ontario, Canada
    • +2 more
    Aug 24, 2022